References
- Elias A D, Ayash L, Anderson K C, Hunt M, Wheeler C, Schwartz G, Tepler I, Mazanet R, Lynch C, Pap S, Pelaez J, Critchlow J, Demetri G, Bibbo J, Schnipper Griffin J D, Frei I II E., Antman K H. Mobilization of blood progenitor cells by chemotherapy and Granulocyte-Macrophage Colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 1992; 79: 3036–3044
- D'Hondt L, André M, Canon J L, Guillaume T, Doyen C, Feyens A M, Chatelain B, Dromelet A, Humblet Y, Longueville J, Symann M. Efficiency of high-dose FEC chemotherapy for mobilizing hematopoietic stem cells into peripheral blood. Bull Cancer 1997; 84: 729–733
- Haas R, Möhle R, Frühauf S, Goldschmidt H, Witt B, Flentje M, Wannenmacher M, Hunstein W. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 8: 3787–3794
- D'Hondt L, André M P, Guillaume T, Feyens A M, Humblet Y, Doyen C, Bosly A, Dromelet A, Chatelain B, Symann M. Quantification of CD34+ cells into peripheral blood predicts the yield of the leukapheresis and can replace the progenitor assays. Cytokines, Cellular Molecular Therapy 1997; 3: 21–26
- Prince H M, Imrie K, Sutherland R, Keating A, Meharchand J, Crump R M, Girouard C, Trip K, Stewart A K. Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections. Brit J Haematol 1996; 93: 142–145
- De Luca E, Sheridan W P, Watson D, Szer J, Begley C G. Prior chemotherapy does not prevent effective mobilization by G-CSF of peripheral blood progenitor cells. Br J Cancer 1992; 66: 893–899
- Bensinger W, Singer J, Appelbaum F, Lilleby K, Rowley S, Clarke E, Clift R, Hansen J, Shields T, Storb R, Weaver C, Weiden P, Buckner C D. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993; 81: 3158–3163
- Höglund M, Bengtsson M, Simonsson B, Smedmyr B, Tötterman T. Leukapheresis with peripheral blood progenitor cells (PBPC) harvest in healthy volunteers receiving different doses of lenogastrim - evidence of a dose response effect. Blood 1994; 84: 1377a
- Dührsen U, Villeval J L, Boyd J, Kannourakis G, Mortsyn G, Metcalf D. Effects of recombinant granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988; 72: 2074–2081
- Makki J, Lefrère F, Rousselot P, Pautier P, Oksenhendler E, Lotz J P, Marroleau J P, Dalcortivo L, Ternaux B, Boulenger G, Benbunan M, Micléa J M. Success of single agent G-CSF for the mobilization of haematopoietic blood cells (HBC) after the failure of mobilization by chemotherapy followed by a growth factor (GF). Hematol Cell Ther 1996; 38: 232a
- Norol F, Haioun C, Divine M, Janvier M, Jouault H, Duedari N, Beaujean F. Efficacité du G-CSF seul après échec de mobilisation des cellules hématopoiétiques sanguines (CSH) par chimiothérapie plus G-CSF. Hematol Cell Ther 1996; 38: 234a
- Demirer T, Buckner C D, Gooley T, Appelbaum F R, Rowley S, Chauncey T, Lilleby K, Storb R, Bensinger W. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Tansplant 1996; 17: 937–941
- Möhle R, Pförisch M, Fruehauf S, Witt B, Kramer A, Haas R. Filgrastim post-chemotherapy mobilizes more CD34+ cells with a different antigenic profile compared with use during steady state hematopoiesis. Bone Marrow Transplant 1994; 14: 827–832
- Perez-Oteyza J, Garcia-Laraña, Ramos R, Zamora C, Lopez-Jimenez J, Roldon E, Odriozola J. Filgrastim post-chemotherapy mobilizes more CD34+ cells compared to its use during steady state haemopoiesis. Bone Marrow Transplant 1995; 16: 324–325